Market Update: Regeneron, UPS, and Zebra
Regeneron (REGN) has seemingly overcome its bear phase, with shares rebounding from $550-$575 to over $650, a 12% jump, following the report of a 0.8% revenue increase to $3.75 billion.
The company posted strong sales of Dupixent, at $4.9 billion, which offset weak sales from EYLEA, although EYLEA HD sales grew by 42% to $663 million. Regeneron also lowered its R&D and SG&A expense forecast for the fiscal year to manage costs.
UPS, despite being down nearly 25% in 2025, saw an 8.0% increase after posting non-GAAP EPS of $1.74 on revenue of $21.4 billion, a 3.6% year-over-year decrease. The stock market rally followed the announcement of a significant 48,000 job cut, with 34,000 cuts in the operational unit and 14,000 at the management level.
Zebra (ZBRA) continued its downturn, which began in August and accelerated in October, with the stock losing 11%.
No direct quotes available in the given text.
Author's summary: Stocks show mixed results with Regeneron rising and UPS cutting jobs.